Analida Yovana-Martinez*, Dana Sulieth-Mena, Lady Johanna-Diaz, Ignacio Salgado Castaneda and Andres Enrique-Becker
Choriocarcinoma is a type of gestational trophoblastic tumor; approximately 20% of patients will require treatment for malignant sequelae after evacuation of a hydatidiform mole. Therefore, rigorous monitoring with quantitative levels of human Chorionic Gonadotropin (hCG) is essential. This type of tumor occurs in about 1 in every 20,000 to 40,000 pregnancies, with a risk of 2-3% after a complete mole. Clinical case: A clinical case of a patient with metastatic choriocarcinoma to the brain, lung and kidney is described, the latter being of low prevalence. The patient did not receive medical follow-up after a complete hydatidiform mole and was diagnosed due to neurological symptoms. So far, she has experienced favorable progress under monitoring of hCG levels. Conclusion, the optimal management of this disease depends on the type of specialized center, the review of the pathology and a treatment based on evidence and clinical guidelines. Given the rarity of trophoblastic tumors, as well as the associated diagnostic challenges, follow-up of hydatidiform molars is crucial to prevent metastasis, as in the case of this patient.